We have surveyed a variety of tumor types and found SHH and Perlecan co-localization in a number of these, such as squamous cell carcinomas and adenocarcinomas of various origins along with tumors deriving from areas of normal Perlecan expression such as chondrosarcomas and osteosarcomas (data not shown). The gene discussed is SHH; the disease is squamous cell carcinoma.